|
| 36785858 | Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program. | | 2023 |
| 36342518 | Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes. | | 2023 |
| 36082513 | Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. | Diabetes, Obesity and Metabolism | 2023 |
| 36443946 | Deciphering the "obesity paradox" in the elderly: A systematic review and meta-analysis of sarcopenic obesity. | Obesity Reviews | 2023 |
| 36424308 | Sonographic Measurement of Mesenteric Fat Thickness Is a Better Predictor of Aortic Stiffness Compared With Conventional Obesity Indexes. | Ultrasound in Medicine and Biology | 2023 |
| 36419741 | The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults. | Lancet Regional Health - Western Pacific, The | 2023 |
| 36394174 | Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes. | Journal of the European Academy of Dermatology and Venereology | 2023 |
| 36446898 | Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. | Nature Reviews Endocrinology | 2023 |
| 37603144 | The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR. | | 2023 |
| 37839755 | Comparison of beta-cell function between Hong Kong Chinese with young-onset type 2 diabetes and late-onset type 2 diabetes. | | 2023 |
| 37634071 | Early treatment with dipeptidyl-peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score-matched cohort study. | | 2023 |
| 37627317 | Divergent Survival Outcomes Associated with Elevated Branched-Chain Amino Acid Levels among Older Adults with or without Hypertension and Diabetes: A Validated, Prospective, Longitudinal Follow-Up Study. | | 2023 |
| 37625035 | Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality: Observational Study of Primary Care Patients in England. | | 2023 |
| 37034649 | Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. | medRxiv | 2023 |
| 36716342 | Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong. | | 2023 |
| 37283964 | Incident cardiovascular-kidney disease, diabetic ketoacidosis, hypoglycaemia and mortality in adult-onset type 1 diabetes: a population-based retrospective cohort study in Hong Kong. | | 2023 |
| 36652944 | Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes. | | 2023 |
| 36965711 | Young-onset diabetes in women with Polycystic Ovary Syndrome: A territory-wide retrospective analysis in Hong Kong. | | 2023 |
| 37139459 | Higher dietary magnesium and potassium intake are associated with lower body fat in people with impaired glucose tolerance. | | 2023 |
| 37074874 | Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes. | | 2023 |
| 36633903 | Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes. | J Clin Invest | 2023 |
| 37188670 | DNA methylation markers for kidney function and progression of diabetic kidney disease. | Nat Commun | 2023 |
| 37125963 | Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes. | Diabetes Care | 2023 |
| 36623286 | Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. | Ann Intern Med | 2023 |
| 37043824 | Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis. | | 2023 |
| 37043089 | Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review. | | 2023 |
| 36457651 | Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study. | eClinicalMedicine | 2023 |
| 36920594 | Adjusting the Use of Glucose-Lowering Agents in the Real-World Clinical Management of People with Type 2 Diabetes: A Narrative Review. | | 2023 |
| 37540646 | Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: A territory-wide population-based cohort study of 1.5 million people in Hong Kong. | | 2023 |
| 34807303 | Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register. | Diabetologia | 2022 |
| 35398277 | Autotaxin signaling facilitates β cell dedifferentiation and dysfunction induced by Sirtuin 3 deficiency. | Molecular Metabolism | 2022 |
| 36183736 | Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. | Lancet Diabetes Endocrinol | 2022 |
| 35528010 | Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease. | Frontiers in Endocrinology | 2022 |
| 36106561 | Hypertriglyceridemia as a main feature associated with 17q12 deletion syndrome-related hepatocyte nuclear factor 1β-maturity-onset diabetes of the young. | Endocrinology, Diabetes and Metabolism Case Reports | 2022 |
| 35970023 | Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019). | eBioMedicine | 2022 |
| 35455439 | A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer. | Pharmaceuticals | 2022 |
| 36356612 | The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. | Lancet Diabetes and Endocrinology,The | 2022 |
| 36297534 | Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate Analyzer and Serum Thromboxane B. | Pharmaceutics | 2022 |
| 35831899 | Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries. | BMC Medicine | 2022 |
| 35830356 | Predictors and Effects of Participation in Peer Support: A Prospective Structural Equation Modeling Analysis. | Ann Behav Med | 2022 |
| 35508700 | Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. | Nat Rev Endocrinol | 2022 |
| 35888723 | Human Serum Metabolites as Potential Mediators from Type 2 Diabetes and Obesity to COVID-19 Severity and Susceptibility: Evidence from Mendelian Randomization Study. | Metabolites | 2022 |
| 36151532 | Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis. | Cardiovascular Diabetology | 2022 |
| 36145361 | Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1-4. | Pharmaceuticals | 2022 |
| 35741723 | Assessment of Bidirectional Relationships between Leisure Sedentary Behaviors and Neuropsychiatric Disorders: A Two-Sample Mendelian Randomization Study. | Genes | 2022 |
| 35685309 | Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes. | Kidney International Reports | 2022 |
| 36272755 | Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. | Kidney Int | 2022 |
| 35934175 | Incidence of long-term diabetes complications and mortality in youth-onset type 2 diabetes: A systematic review. | Diabetes Research and Clinical Practice | 2022 |
| 35551307 | Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. | Nat Genet | 2022 |
| 36067582 | A diet high in FODMAPs as a novel dietary strategy in diabetes? | Clinical Nutrition | 2022 |